One possible explanation for the association between the creatinine-cystatin C ratio and the outcome of CRC patients is that the creatinine-cystatin C ratio represents muscle mass, which is a well-known risk factor for the outcome of CRC patients (21). This evidence concerns the gene CST3 and colorectal carcinoma.